Return On Assets of Aclaris Therapeutics, Inc. from 30 Jun 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Aclaris Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Jun 2016 to 30 Sep 2025.
  • Aclaris Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -72%, a 250% decline year-over-year.
  • Aclaris Therapeutics, Inc. annual Return On Assets for 2024 was -72%, a 78% decline from 2023.
  • Aclaris Therapeutics, Inc. annual Return On Assets for 2023 was -40%, a 19% decline from 2022.
  • Aclaris Therapeutics, Inc. annual Return On Assets for 2022 was -34%, a 10% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Aclaris Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -72% -52% -250% 01 Jul 2025 30 Sep 2025
Q2 2025 -68% -37% -118% 01 Apr 2025 30 Jun 2025
Q1 2025 -68% -31% -83% 01 Jan 2025 31 Mar 2025
Q4 2024 -72% -31% -78% 01 Oct 2024 31 Dec 2024
Q3 2024 -21% +28% +58% 01 Jul 2024 30 Sep 2024
Q2 2024 -31% +11% +27% 01 Apr 2024 30 Jun 2024
Q1 2024 -37% 0% -0.13% 01 Jan 2024 31 Mar 2024
Q4 2023 -40% -6% -19% 01 Oct 2023 31 Dec 2023
Q3 2023 -49% -17% -52% 01 Jul 2023 30 Sep 2023
Q2 2023 -43% -10% -31% 01 Apr 2023 30 Jun 2023
Q1 2023 -37% -6% -19% 01 Jan 2023 31 Mar 2023
Q4 2022 -34% +4% +10% 01 Oct 2022 31 Dec 2022
Q3 2022 -32% +9% +23% 01 Jul 2022 30 Sep 2022
Q2 2022 -33% +15% +32% 01 Apr 2022 30 Jun 2022
Q1 2022 -31% +35% +52% 01 Jan 2022 31 Mar 2022
Q4 2021 -38% +25% +40% 01 Oct 2021 31 Dec 2021
Q3 2021 -41% +23% +35% 01 Jul 2021 30 Sep 2021
Q2 2021 -48% +44% +48% 01 Apr 2021 30 Jun 2021
Q1 2021 -66% +31% +32% 01 Jan 2021 31 Mar 2021
Q4 2020 -63% +26% +29% 01 Oct 2020 31 Dec 2020
Q3 2020 -64% +16% +20% 01 Jul 2020 30 Sep 2020
Q2 2020 -92% -23% -33% 01 Apr 2020 30 Jun 2020
Q1 2020 -97% -36% -58% 01 Jan 2020 31 Mar 2020
Q4 2019 -89% -28% -46% 01 Oct 2019 31 Dec 2019
Q3 2019 -80% -24% -44% 01 Jul 2019 30 Sep 2019
Q2 2019 -69% -25% -56% 01 Apr 2019 30 Jun 2019
Q1 2019 -62% -24% -62% 01 Jan 2019 31 Mar 2019
Q4 2018 -61% -28% -88% 01 Oct 2018 31 Dec 2018
Q3 2018 -56% -26% -90% 01 Jul 2018 30 Sep 2018
Q2 2018 -44% -11% -35% 01 Apr 2018 30 Jun 2018
Q1 2018 -38% -2% -5.3% 01 Jan 2018 31 Mar 2018
Q4 2017 -32% +11% +25% 01 Oct 2017 31 Dec 2017
Q3 2017 -29% +16% +36% 01 Jul 2017 30 Sep 2017
Q2 2017 -33% +19% +37% 01 Apr 2017 30 Jun 2017
Q1 2017 -36% 01 Jan 2017 31 Mar 2017
Q4 2016 -43% 01 Oct 2016 31 Dec 2016
Q3 2016 -45% 01 Jul 2016 30 Sep 2016
Q2 2016 -52% 01 Apr 2016 30 Jun 2016

Aclaris Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -72% -31% -78% 01 Jan 2024 31 Dec 2024
2023 -40% -6% -19% 01 Jan 2023 31 Dec 2023
2022 -34% +4% +10% 01 Jan 2022 31 Dec 2022
2021 -38% +25% +40% 01 Jan 2021 31 Dec 2021
2020 -63% +26% +29% 01 Jan 2020 31 Dec 2020
2019 -89% -28% -46% 01 Jan 2019 31 Dec 2019
2018 -61% -28% -88% 01 Jan 2018 31 Dec 2018
2017 -32% +11% +25% 01 Jan 2017 31 Dec 2017
2016 -43% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.